Navigation Links
Amgen Backs States' Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety
Date:1/25/2013

THOUSAND OAKS, Calif., Jan. 25, 2013 /PRNewswire/ -- In conjunction with our oncology biosimilars partner Actavis' announcement earlier today of our four oncology biosimilars products, Amgen (NASDAQ: AMGN) today stated that it supports state biosimilars initiatives that focus on sound science and patient safety. As a biotech company developing both innovator biologics and biosimilars, Amgen believes that patient safety does not stop at drug approval. 

"Amgen endorses state policies that would put patients first and, in doing so, increase confidence in the biosimilar pathway. It is important to have consistent policies in place at the federal and state level," said Scott Foraker , vice president and general manager of biosimilars at Amgen. 

States' efforts to create safe substitution rules for interchangeable biologics will help accelerate the successful implementation of the U.S. biosimilars pathway. Regulatory authorities in Europe and the U.S. have emphasized the need for long-term safety monitoring of biologics. Biologic medicines are different than traditional chemical drugs in several important ways. Biologics are so complex that they can usually only be made by a living cell.  In fact, when made by different manufacturers, they differ from each other.  They are also very large compared to chemical drugs and can be more sensitive to storage and handling. As a result biologic medicines have the potential to cause an unwanted immune response, which can show up months after taking the medicine. This emphasizes why Amgen believes state pharmacy acts must enhance safety monitoring of substituted biologics.

Amgen is helping educate state policymakers on these considerations to ensure that physicians, patients and pharmacists share important in
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Amgens Full Year 2012 Revenues Increased 11 Percent To $17.3 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $6.51
2. Amgen Announces 31 Percent Increase In 2013 First Quarter Dividend And Increase In Its Share Repurchase Authorization
3. Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
4. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
5. Amgen To Present Data From Four Phase 2 Studies At Upcoming American Heart Association Scientific Sessions 2012
6. Amgen Supports Assistance for Patients Affected by Hurricane Sandy
7. Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference
8. Amgen To Present At The Morgan Stanley Global Healthcare Conference
9. Amgen To Present At The Baird Healthcare Conference
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... HILL, N.C. , May 24, 2013 /PRNewswire/ ... to the forefront of many organizations, priority list. ... and medical device sectors understand a strong ... current challenges in clinical development, market education ... effectively to create a vital bridge between an ...
(Date:5/24/2013)... 2013  BD (Becton, Dickinson and Company) (NYSE: ... that it will present at the Deutsche Bank 38 th ... at 10:40 a.m. (ET). A live webcast ... website at www.bd.com/investors and will be available for ... BD BD is a leading global medical technology ...
(Date:5/24/2013)... , May 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses ... non-profit substance abuse services organization, is hosting its tenth ... Hills Hotel on June 6, 2013.  More than 300 ... funds for the adolescent residential treatment centers, family therapy, ... honor individuals whose accomplishments have positive influences on the ...
Breaking Medicine Technology:Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3
... the European League Against Rheumatism,(EULAR) Congress Demonstrates ... Rheumatoid Arthritis, LONDON, England; PHILADELPHIA, Pennsylvania and ... and Genmab A/S (CSE: GEN) announced today ... to be presented at EULAR,2007, the Annual ...
... N.Y., June 15, 2007 /PRNewswire-FirstCall/ -- EpiCept,Corporation today ... that Azixa(TM) (MPC-6827) is effective in treating,multiple types ... a,mechanism by which MPC-6827 exerts its effects, and ... proteins known to be involved,in cancer drug resistance. ...
Cached Medicine Technology:GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 2GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 3GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 4GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 2New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 3New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 4New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 6
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 – ... Materials, Packaging, & Geography: Trends & Forecasts” defines ... analysis and forecasting of the global revenue for ... restraining factors for the global food encapsulation markets ... market is segmented and revenue are forecasted on ...
(Date:5/25/2013)... States (PRWEB) May 25, 2013 ... largest underground shelter company in the US and ... underground structures for over 35 years. M.E. and ... U.S. Handbook of NBC Weapon Fundamentals and Shelter ... United States’ bible on shelter engineering. McCarthy is ...
(Date:5/25/2013)... 2013 Studies from Johns Hopkins University ... excessive weight and their inability to get adequate sleep. ... weight can naturally relieve many symptoms. , Johns ... sleep quality was significantly associated with overall weight loss, ... dated November 6th, 2012, researchers monitored 77 participants ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Providing patients with ... Diet Doc team of weight management professionals. But, aside from ... and effectively, Diet Doc’s hCG diets also provide ... abuse during childhood like bullying, more control over their lives ... of dealing with the underlying factors of weight gain derived ...
(Date:5/25/2013)... 25, 2013 Absolute Surgical Specialists, serving Sun ... the NALA’s businesses throughout the country participating in Shop Local ... in the nationwide event as he understands what military families ... the Army. He said, “I wanted to give something back, ... but I live here too.” , Shop Local for a ...
Breaking Medicine News(10 mins):Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2
... ... symptoms in rats with a disease designed to mimic Parkinson,s disease. , ... San Francisco, CA (Vocus) March 25, 2010 -- ... a disease designed to mimic Parkinson,s disease., , , , ,The strategy suggests a promising ...
... CINCINNATI Identification of two new proteins in the ... instability in people with Fanconi anemia and how otherwise ... DNA damage. A study in the March 26 ... to the multifaceted Fanconi anemia (FA) pathway. The research ...
... Topics in ... What is cloud server web hosting, 4. Lunch date for much cheaper web hosting, 5. How ... , ... -- On March 25th 2010 Omega One Media will be launching cloud server technology in their ...
... , ... Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today ... the growing training and information needs of physicians and other medical professionals ... access site. As transradial adoption expands in the U.S., two key ...
... ... Price and Flavor Needs , ... Qufu, China and Erlanger, KY (PRWEB) March 25, 2010 -- Sunwin International ... extracts, and WILD Flavors, Inc. ("WILD Flavors"), a global leader in food, beverage and ...
... the standard hepatitis C (HCV) therapy, pegylated interferon and ... treated in an ordinary clinical practice setting compared with ... study appear in the April issue of Hepatology ... the American Association for the Study of Liver Diseases. ...
Cached Medicine News:Health News:Novel Parkinson's Treatment Strategy Involves Cell Transplantation 2Health News:Novel Parkinson's Treatment Strategy Involves Cell Transplantation 3Health News:Novel Parkinson's Treatment Strategy Involves Cell Transplantation 4Health News:Newly identified proteins critical to FA pathway DNA repair function 2Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 2Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 3Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 4Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 5Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 6Health News:U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need 2Health News:U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need 3Health News:U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need 4Health News:Sunwin International & WILD Flavors Receive GRAS Letters of No Objection from FDA Validating Safety of Multiple Sunwin Stevia Extracts 2Health News:Sunwin International & WILD Flavors Receive GRAS Letters of No Objection from FDA Validating Safety of Multiple Sunwin Stevia Extracts 3Health News:Hepatitis C treatment less effective in urban minority patients 2Health News:Hepatitis C treatment less effective in urban minority patients 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: